Developers
Only 1 of 25 cancer drug developers fairly included minority patients over five-year window, BMJ analysis finds
New clinical trial diversity plans, which FDA will soon explain further, were featured in the government spending package that President Joe Biden ...
The FDA weighs in on market research and drug developers are listening – especially to the underserved – PharmaLive
The FDA weighs in on market research and drug developers are listening – especially to the underserved
By Fabio Gratton
A new era of FDA guidance
T...
Sol-REIT Secures a Warehouse Credit Facility Led by Amerant Bank to Support Clean Energy Developers
[May 17, 2022]
Sol-REIT, which is revolutionizing clean energy financing through innovative construction-to-permanent loans leveraging a mortga...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.